1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with limaprost in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (limaprost) | Trials (limaprost) | Recent Studies (post-2010) (limaprost) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 76 | 11 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hecker, G; König, E; Ney, P; Schrör, K | 1 |
| Hecker, G; Ney, P; Schröder, H; Schrör, K | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and limaprost
| Article | Year |
|---|---|
Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206.
Topics: Alprostadil; Blood Platelets; Epoprostenol; Humans; Iloprost; Kinetics; Neutrophils; Platelet Activating Factor; Platelet Aggregation | 1987 |
Potent inhibition of leukotriene (LT) B4 release from human polymorphonuclear leukocytes (PMN) by the PGE1-analogue OP-1206.
Topics: Alprostadil; Dinoprostone; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Leukotriene B4; Neutrophils; Platelet Activating Factor; Prostaglandins E, Synthetic | 1988 |